Clinical Implications of Ambulatory and Home Blood Pressure Monitoring by Kim, Soon-Gil
423
Print ISSN 1738-5520 / On-line ISSN 1738-5555
Copyright © 2010 The Korean Society of Cardiology
REVIEW
DOI 10.4070 / kcj.2010.40.9.423
Open Access
Clinical Implications of Ambulatory and  
Home Blood Pressure Monitoring
Soon-Gil Kim, MD
Division of Cardiology, Guri Hospital, Hanyang University College of Medicine, Guri, Korea
ABSTRACT
Because blood pressure (BP) is an ever changing hemodynamic phenomenon, a BP value, once measured at a physician’s office 
(Office BP), is often unrepresentative of an individual’s true BP status. Both ambulatory blood pressure monitoring (ABPM) and 
home blood pressure monitoring (HBPM) provide more accurate and reproducible estimate of BP, and produce stronger pre-
dictive ability for cardiovascular outcome than conventional office BP. Two BP measuring techniques, ABPM and HBPM have 
been widely in clinical use for the detection and management of hypertension. However, they have different advantages and 
limitations in practice. At present, it has become crucial to understand the characteristics and clinical implications of these BP 
measuring techniques for those responsible for the care of hypertensive patients. (Korean Circ J 2010;40:423-431)
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Introduction
Arterial blood pressure (BP) is a continuously changing he-
modynamic phenomenon that can be influenced by many 
factors, including an individual’s physical and emotional sta-
tus, and environmental circumstances. It is also controlled by 
the autonomic nervous system, renin-angiotensin-aldosterone 
system and other numerous neurohumoral factors. Therefore, 
once a BP value is measured at a physician’s office (office BP), 
it may not truthfully represent the individual’s BP status.
1)
Both ambulatory blood pressure monitoring (ABPM) and 
home blood pressure monitoring (HBPM) are alternative me-
thods of measuring BP. They may overcome the problems 
associated with office BP measurements. 
In the past 30 years, these two main BP measuring techni-
ques have been widely used in clinical practice. Since then the 
awareness of the limitations of office BP measurement has 
been raised, and wider availability of simple and accurate 
ABPM and HBPM devices have been made available.
1)2) Ini-
tially, ABPM was considered as an investigational tool and 
its used was confined to specialized hypertension centers due 
to its relatively high cost and inconvenience in the clinical 
application,
3-5) but over the years its availability has gradually 
increased. On the other hand, physicians have been reluctant 
in using HBPM in the routine management of hypertensive 
patients. Rather, it has spread through the non-medical elec-
tronic device market in some countries. The official validation 
of these equipments must be determined before clinical use. 
At present, up-to-date lists of validated monitors are available 
through the Internet.
2)6)
It is widely accepted that both ABPM and HBPM provide 
more reliable BP measurements, and give better prediction of 
organ damage and the risks of cardiovascular (CV) complica-
tions than office BP. However, there are some differences in 
the clinical usefulness and limitations between ABPM and 
HBPM.
7)8)
 
Ambulatory Blood Pressure Monitoring 
 
ABPM provides automated measurements of arterial BP 
for 24 hours or longer, while patients go about their usual dai-
ly activities. Most modern ABPM monitors use the oscillo-
metric technique. They weigh only less than 1 kg, and can be 
simply worn on a belt, and are connected to a sphygmoma-
nometer cuff on the upper arm by a rubber tube. The monitors 
are programmed to take readings at desired intervals, usual-424   Ambulatory and Home Blood Pressure Monitoring
ly every 15 to 30 minutes, throughout the day and night.
1) At 
the end of the recording, the readings are downloaded onto a 
computer which is programmed to process the data using 
various parameters (Table 1).
There is accumulated evidence that demonstrate the prog-
nostic value of ABPM.
9-23) The Ohasama study was conduct-
ed on a general population in a Japanese rural area.
11) They re-
ported more distinctive association between ambulatory BP 
and CV mortality than that between office BP and CV mortal-
ity. After adjustment for age, gender, smoking status, baseline 
office BP, and the use of antihypertensive drugs, the risk of CV 
mortality during a follow-up period of 5.1 years was increased 
in the highest quintile of the distribution of average 24-hour 
systolic BP, whereas there was no significant association between 
office BP and the CV mortality. It was the first study to address 
the prognostic value of ABPM in the general population. 
In a subgroup setting of the Systolic Hypertension in Eu-
rope (Syst-Eur) study, the association of ambulatory blood pres-
sure (ABP) with the CV risk was evaluated.
14) The Syst-Eur 
study was a randomized double-blind clinical trial which vali-
dated the efficacy of active treatment with a calcium channel 
blocker-based regimen in older patients with isolated systol-
ic hypertension.
24) At the time of randomization, ABPM was 
performed in 808 patients of whom 98 patients developed ma-
jor CV events during a median follow-up period of 4.4 years. 
After adjusting for sex, age, previous CV complications, smok-
ing, and residency in Western Europe, higher 24-hour BP was 
associated with total, cardiac, and cerebrovascular events in 
untreated hypertensive patients. For every 10-mmHg increase 
in mean 24-hour BP, hazard rate for total and CV mortality 
was 1.23 {95% confidence interval (CI), 1.00-1.50} and 1.34 
(95% CI, 1.03-1.75) respectively. In the untreated patients 
group, the night-time systolic BP predicted end points more ac-
curately than did daytime BP. 
 
Definition of normality for ambulatory blood 
pressure monitoring
There has been much debate on the definition of diagnostic 
thresholds for ABP. According to recent guidelines for the BP 
measurement, an average daytime ABP of less than 135 mmHg 
systolic, and 85 mmHg diastolic is generally considered nor-
mal. This cut-off has been thought to be reasonable because 
it corresponds approximately to an office BP of 140/90 mmHg. 
The threshold value for the average night-time ABP is 120 
mmHg systolic, and 70 mmHg diastolic.
1)25) 
However, more recently, a collaborative population based 
CV outcome-driven study proposed lower diagnostic thresh-
olds for ABPM. The International Database on Ambulatory 
BP monitoring in relation to Cardiovascular Outcome (IDA-
CO) study
26) was designed as a population based longitudi-
nal follow-up CV outcome study. Twenty-four hour ABPM was 
performed on 5,682 participants enrolled in the prospective 
population studies in Denmark (Copenhagen), Belgium (No-
orderkempen), Japan (Ohasama), and Sweden (Uppsala). In 
multivariate analyses, the ABP thresholds were determined, 
which yielded 10-year CV risks similar to that associated with 
optimal (120/80 mmHg), normal (130/85 mmHg), and high 
(140/90 mmHg) BP on office measurement. Over 9.7 years of 
follow-up, 814 CV end point events were recorded. The ro-
unded optimal, normal and high ABP are as follows: systol-
ic/diastolic thresholds for optimal ABP were 115/75 mmHg for 
24 hour, 120/80 mmHg for the daytime, and 100/65 mmHg 
for the nighttime. Corresponding rounded threshold for nor-
mal ABP were 125/75, 130/85, and 110/70 mmHg, respective-
ly. That for ambulatory hypertension were 130/80, 140/85, and 
120/70 mmHg, respectively. Eventually, these values came out 
lower than that currently proposed by hypertension guide-
lines (Table 2).
27) However, one should remember that the 
ABP value is a continuous variable, and the relationship be-
tween CV outcomes and BP is also continuous. Therefore, a 
critical level can not be pinpointed, above which the risk sud-
denly rises.
28)
Table 1. Parameters for usual analysis of data in ambulatory blood 
pressure monitoring in clinical practice
• Mean 24 hour BP
• Mean daytime BP
• Mean nighttime BP
•   Day to night BP change: Dipper and non-dipper  (Night-to-day
 BP ratio)
• Early morning surge
• BP variations
BP: blood pressure 
Table 2. Threshold blood pressure values proposed by the IDA-
CO study compared with ESH guidelines (average systolic BP/di-
astolic BP mmHg)
IDACO 
database
ESH 
guidelines (2005)
OptimalBP
24-hour <115/75 -
Daytime <120/80 <130/80
Nighttime <100/65 <115/65
NormalBP
24-hour <125/75 -
Daytime <130/85 <135/85
Nighttime <110/70 <120/70
Ambulatory hypertension
24-hour ≥130/80 -
Daytime ≥140/85 >140/90
Nighttime ≥120/70 >125/75
IDACO: the International Database on Ambulatory blood pressure 
monitoring in relation to Cardiovascular Outcomes, ESH: the Eu-
ropean Society of Hypertension, BP: blood pressureSoon-Gil Kim   425
Day-night blood pressure changes
In subjects with normotension or hypertension, a prono-
unced diurnal rhythm of BP is present. BP usually falls dur-
ing the first few hours of sleep, and there is a marked rise in the 
morning coincidently with the transition from sleep to wake-
fulness. The average difference between waking and sleeping 
systolic and diastolic BP is 10-20%. In some subjects, the nor-
mal nocturnal fall of BP is diminished (<10%), and they are 
referred to as “non-dippers”, in contrast to normal “dippers”.
29) 
In extreme cases, BP rises during the night (reverse dippers). 
The non-dipping pattern has multiple causes, such as highly 
active adrenergic activity during the night, poor quality of sleep, 
presence of renal disease, and use of corticosteroids.
6) The clas-
sification of ‘non-dipper’ or ‘dipper’ is based on the hypoth-
esis that target organ damage and prognosis are worse when 
BP load is persistent throughout a 24 hour period, than when 
it is limited to the daytime hours. Because BP is a continu-
ous variable, an arbitrary dichotomization, such as the dipper/
non-dipper classification has been criticized. Therefore, an 
analysis of the diurnal change of BP as a continuous variable 
could be more reasonable. The day-night BP changes or the 
day-night BP ratio will be more useful than a dichotomous 
classification, such as dipper and non-dipper, in this point of 
the view.
30) 
In subjects with diminished or abolished fall in BP from 
day to night, not only left ventricular hypertrophy,
31-34) but also 
silent cerebrovascular disease,
35) microalbuminuria,
36) and pro-
gression of renal damage
30) were greater than in those with nor-
mal day-night BP difference.
A blunted day-night changes of BP has a greater prognostic 
significance. It appears that regardless of one’s BP status, a non-
dipper has poorer CV outcome. In the Ohasama study, Ohku-
bo et al.
37) found an increased CV mortality in non-dippers (re-
lative risk 2.56, p=0.02), and inverted dippers (relative risk 3.69, 
p=0.004) compared with dippers.
As mentioned earlier, in the analysis of Syst-Euro study,
14) 
the night/day ratio of ambulatory systolic BP was an indepen-
dent predictor of CV events in the patient group randomized 
to placebo. It suggests that the mean night-time BP has a bet-
ter predictive value than the mean daytime BP, although some 
reports have shown no difference in the predictive power for 
CV risk between night-time and daytime BP.
38) In the previ-
ously mentioned IDACO study analysis, this long term fol-
low-up prospective cohort study showed that when adjusted 
for the daytime BP, night-time BP more accurately predicted 
total and CV mortality than daytime BP.
39) This is the reason 
why recording ABPM throughout the day is necessary. ABPM 
is the unique technique capable of recording a series of night-
time BP non-invasively in modern clinical practice. 
 
Blood pressure variability 
BP variability is measurable in many different ways, rang-
ing from beat-to-beat changes, to changes over periods of weeks 
or months (Table 3). It may also show seasonal variation or 
daily changes (circadian variation). The day-night BP change 
is a typical example of circadian variation. Because the read-
ings are taken intermittently during ABPM, we can only obtain 
a crude estimation of the true variations, as hour-to-hour 
(ultradian) or measure-to-measure variations. The calculat-
ed standard deviations (SD) of the readings of 24-hour, day-
time, and nighttime BP are also crude estimations of an ultra-
dian variation. In studies on ABPM, the frequency and se-
verity of target organ damage were greater in subjects with 
high SD of BP readings than in those with low SD.
40)41) In the 
Progetto Ipertensione Umbra Monitoraggio Ambulatoriale 
study,
42) the rate of major CV morbid events was higher in 
subjects with SD of the daytime or the night-time systolic BP 
above the group mean, compared to those with SD below 
the group mean. However, this difference vanished in the Cox 
multivariate analysis after adjustment for age, diabetes, pre-
vious CV events, and ABP. 
The mechanisms and contributing factors to BP variability 
are still not completely understood. The seasonal, day-to-night 
changes or measure-to-measure variations may have differ-
ent mechanisms from each other, and they can also be influ-
enced by different contributing factors. This needs to be clar-
ified, and the association between CV risk and BP variability 
also remains to be determined.
Kario et al.
43) reported that a higher morning BP surge was 
associated with stroke risk, independent of ABP, nocturnal BP 
fall, and the presence of silent cerebral infarction in elderly 
hypertensives. They define morning surge as the difference be-
tween morning systolic BP (average of four readings after aw-
aking) and the lowest systolic BP during sleep (average of three 
BP readings centered on the lowest nighttime reading). They 
found that a 10 mmHg increase in this surge was associated 
with 22% (95% CI, 5-40%) increased risk in stroke events.
On the contrary, the Syst-Eur study
24) showed that a large 
morning surge was associated with significantly lower risk 
of total CV events in untreated elderly hypertensive patients. 
These results indicated a lower risk of the morning surge in BP, 
and are consistent with the strong predictive value of night-
time BP that was also identified in this study. In the Ohasa-
Table 3. Theoretical classification of blood pressure (BP) variation
Seasonal variation
Circadian variation
Hour to hour variation (ultradian variation)
Measure to measure variation
Beat to beat variation
Standard deviation of BP measurements
Power spectral variability (high and low frequency)
Chaotic variation (complexity)426   Ambulatory and Home Blood Pressure Monitoring
ma study,
44) they found that a higher magnitude of morning 
surge tended to be associated with an increased risk of cere-
bral hemorrhage, but not with the risk of cerebral infarction 
during a mean follow period of 10.4 years in 1,430 individu-
als in a general population.
Such discrepancy between these prospective studies is due 
to different study populations, relatively small number of 
events, and differences in definitions and target outcomes. To 
elucidate the prognostic significance of the morning surge in 
BP more precisely, larger prospective studies with longer fol-
low-up periods, including a variety of outcomes, are required.
45)
White coat hypertension and white coat effect
White coat hypertension (WCH), also referred to as “iso-
lated office hypertension”, is generally defined as persistently 
high office BP, with a normal BP outside the office.
1)30) The 
alerting reaction to a visit into the physician’s office may cause 
transient elevation in BP. The diagnosis of WCH is impor-
tant, because it is generally accepted that patients with WCH 
have relatively low CV risk and are unlikely to benefit from an-
tihypertensive pharmacologic therapy.
6) The Ohasama study
46) 
also showed that CV morbidity was lower in WCH than in 
ambulatory hypertension, and was not dissimilar between 
WCH and clinical normotension in a mixed population of 
treated and untreated subjects. However, the prognosis is 
not always benign. Some studies identified that more frequent 
target organ damage was present in WCH than clinical nor-
motension.
47) In long-term follow up studies, CV risk was in-
crease in patients with WCH. According to an analysis of the 
pooled data of four different cohort studies, sustained hyper-
tension may develop in some patients with WCH, and the risk 
of stroke may increase after a mean follow-up period of six 
years.
48) It could reflect a higher inherent risk in subjects with 
WCH of developing sustained hypertension in the long run.
49) 
Therefore, in patients with WCH, long-term follow up with re-
peated ABPM or HBPM is necessary.
6)
WCH must to be distinguished from the “white coat effect” 
or “white coat phenomenon”, which is the term used to descri-
be transient increase in BP that occurs in a medical environ-
ment regardless of the ABP status of patients. Measuring BP in 
the physician’s office may trigger an alerting reaction, which 
causes a rise in BP. The white coat effect is found in many hy-
pertensive patients, whereby the office BP is usually greater 
than the average daytime ABP.
1) Patients diagnosed with se-
vere hypertension by office BP may have only mild hyperten-
sion on ABPM, due to marked white coat effect. 
It could elicit misinterpretation of the patient’s BP status 
from the physician responsible for the hypertension manage-
ment. Physicians are likely to identify patients with poorly 
controlled BP, when in fact they have normal ABP. For correct 
diagnosis of white coat effect, ABPM and HBPM are very use-
ful in clinical practice.
1)2)6)
Masked hypertension
“Masked hypertension (MH)” or “Reverse white coat hy-
pertension” is defined as having a normal office BP and a high 
ambulatory or home BP.
50) MH was associated with poor 
CV outcome in a population based study of untreated elder-
ly patients.
18) After adjustment for CV risk factors, MH was 
an independent predictor of CV morbidity when compared 
to normotensive subjects. The Ohasama study with 24-hour 
ABPM confirmed an excessive risk of events in subjects with 
MH, compared to subjects with normal office and ABP.
46) When 
people already have MH, it follows that they should be re-
garded as being genuinely hypertensive.
1) Identifying MH is 
substantially important in treated patients. The mechanisms 
responsible for this phenomenon may be different between 
treated and untreated patients. Drug treatment may elicit a 
different drop in office BP and ABP attributable to time of ad-
ministration with respect to the visit and duration of action 
of drugs. In treated patients, high prevalence of MH may be 
partly explained by the fact that the office BP is often taken 
at the time of peak drug effect, whereas ABP or home BP may 
be taken at its trough, which is particularly evident when short-
acting drugs are taken.
2)
A study showed that the prevalence of MH was present in 
one third of treated hypertensive patients in a hypertension 
clinic. Over five-years of follow-up, their relative risk for CV 
events was 2.28, as compared to patients whose office and ABP 
were adequately controlled.
51) 
The challenge for clinical practice is how to identify and ma-
nage these patients, because the prevalence of MH is estimat-
ed to be more than 10 percent of the general population. MH 
may be suspected in individuals who have had an increased 
office BP at some time, in young persons with a normal or 
high-normal office BP who had early target organ damage, in 
individuals with a family history of hypertension in both par-
ents, patients with multiple risks for CV disease, and proba-
bly diabetic patients.
1)
Home Blood Pressure Monitoring
Over the decades HBPM has been used mostly by patients 
regardless of physician concern. It was spread via the health 
care equipment markets in some countries. However, it has 
recently become increasingly popular and is now gaining more 
acceptance by patients and physicians, because not only the 
importance of out-of-office BP measurement has been widely 
accepted but also more reliable automatic devices have been 
made available in the market.
2)52) 
A modern HBPM monitor is very simple and weighs under 
1 kg, with a sphygmomanometer cuff connected to a rubber 
tube which in turns connect to the body of the device. BP is 
very easily measured using automated oscillometric technique, 
as by ABPM.Soon-Gil Kim   427
Methodological aspects
Because not all HBPM devices on the market have fulfilled 
the validation criteria, it is essential to choose a validated de-
vice for clinical use. The European Society of Hypertension 
(ESH) and the British Hypertension Society (BHS) have sup-
ported the establishment of websites to provide updated lists 
of validated BP-measuring devices (www.dableducational.
org and www.bhsoc.org respectively).
Detailed description of the technical aspects of device sel-
ection and BP measurement is beyond the scope of this arti-
cle. More precise information can be found in the BP meas-
urement guidelines published by the international academic 
and professional societies.
1)2)
Selection of the optimal schedule for HBPM should include 
consideration for its ability to provide reliable and reproduc-
ible assessment of the usual home BP for each individual. Ac-
cording to outcome studies and clinical pharmacologic trials 
using HBPM, to achieve the optimal prognostic power, a 7-day 
schedule with duplicate morning and evening home BP meas-
urements was suggested as appropriate.
53) The ESH Working 
Group on BP monitoring recommended that for the evalua-
tion of hypertensive patients, home BP should be monitored 
for seven days, with at least two morning and two evening me-
asurements. To enable clinical decision-making, the average 
of all values should be used, with the exception of the first 
day values, which should de discarded. Because home BP val-
ues on the initial monitoring day were shown to be higher and 
more unstable, discarding them improves the reproducibili-
ty of home BP measurement.
1)2)
Because the association between BP and CV risk is contin-
uous, it is difficult to determine a cut-off diagnostic hyperten-
sion threshold for HBPM. According to longitudinal popu-
lation and patients cohort studies, the suggested thresholds 
differ slightly between them.
21)54-56) However, a practical agree-
ment has been made on the diagnostic threshold by interna-
tional professional societies, which was 135 mmHg for systol-
ic and 85 mmHg for diastolic home BP.
1)2) It is very close to 
the diagnostic threshold of the mean daytime BP for ABPM.
The target home BP for therapy should logically be below 
the threshold used to diagnose hypertension. That is, it should 
be lower than 135 mmHg systolic and lower than 85 mmHg 
for diastolic home BP. Much lower home BP targets are ad-
vised in high risk patients, such as those with diabetes mellitus, 
a history of stroke, coronary heart disease or renal disease.
2)
Advantages of home blood pressure monitoring
By using HBPM, it is possible to take BP measurement re-
peatedly over long periods of time, which allows more reli-
able estimates of BP. Therefore HBPM predicts clinical out-
comes of hypertension better than office BP measurements 
(Table 4).
For diagnosis and management of WCH and MH, HBPM 
is also as useful as ABPM. The prevalence of these two condi-
tions in the general population is relatively high in the litera-
ture (15-20% for WCH and 10-15% for MH).
2)46) Even though 
such results have been obtained using ABPM, HBPM also 
provided similar estimates, although the results obtained with 
the two techniques do not overlap completely.
2)57)
In treated hypertensive patients, improved long-term con-
trol of hypertension is expected by HBPM use. It has the abil-
ity to provide information about BP control outside the of-
fice, thereby facilitating the identification of treated hyper-
tensive patients with WCH or MH. 
WCH is also highly prevalent in treated hypertensive pa-
tients, which means that many patients who appear to be re-
fractory to treatment in the doctor’s office may have adequate-
ly controlled BP at home. In those patients, HBPM can be he-
lpful both in confirming or in rejecting the diagnosis of re-
sistant hypertension.
2)58) 
The identification of treated patients with MH may be even 
more important, because this condition appears to be com-
mon and is associated with similar CV risk to sustained un-
controlled hypertension.
59) Because identifying patients with 
WCH and MH is difficult in clinics, ideally HBPM should be 
performed in all treated hypertensive patients, even if they 
have controlled office BP. It is more strongly recommended 
to perform HBPM in patients likely to have MH, especially 
patients with high normal BP, who have high risk of CV dis-
eases, and those with evidence of target organ damage, or those 
diagnosed with CV disease.
2)
Uncontrolled hypertension is usually caused by poor pa-
tient adherence to therapy. HBPM is the BP measurement 
Table 4. Advantages and limitations of home blood pressure moni-
toring
Advantages
Reliable estimation of BP: multiple readings in long period
Diagnosis and classification of HT: white coat and masked HT
Prediction of CV risk
Improvement in compliance of patients
Improved control of BP during treatment
Reduced cost of long-term care
Possibility of digital storage and telemonitoring
Limitations
Need of patient training
Lack of nighttime BP during sleep
Poor reliability of BP values reported by patients
Induction of anxiety resulting in excessive monitoring
Possibility of self-modification of drug by patients
Inaccurate estimation of BP in patients with arrhythmias
Relative lack of clinical research data for normality threshold 
and therapeutic targets
BP: blood pressure, CV: cardiovascular, HT: hypertension428   Ambulatory and Home Blood Pressure Monitoring
method that requires particular cooperation from the patient, 
therefore it may affect favorably on patients’ perception of their 
disease, and encourage them to be more compliant with life-
style modifications and antihypertensive drug therapy.
60)
Most validated modern HBPM devices are easy to meas-
ure BP using the oscillometric technique. New devices with 
special functions useful in particular clinical situations are 
subsequently developed. Digitized data can be stored in some 
devices, and can be analyzed with built-in software. Other 
features which may be useful in some patients are developed 
including external computer connectivity, possibility of print-
out, automated nighttime measurements, possibility of sel-
ecting specific time periods for statistical analysis, and tele-
monitoring.
2)
Limitations of home blood pressure monitoring
Generally, HBPM devices are thought to be very easy to 
use, and frequently patients monitor BP on their own initia-
tive, using purchased devices without medical advice. How-
ever, for accurate measurement and precise interpretation of 
BP, patients need be trained properly. Patient education must 
include selection of appropriate devices, with proper cuff 
size and measurement methodology (Table 4).
2)61)
In fact, usually HBPM is unable to measure night-time 
sleeping BP. On the contrary, ABPM is able to provide a series 
of frequent and automated BP measurements throughout 
the 24-hour period. It may be a major disadvantage of HBPM, 
compared to ABPM. Therefore, with the use of HBPM, it is 
not possible to analyze BP changes over relative short periods 
of time, including day-night BP difference, BP variability and 
excessive morning BP surge, which may have clinical implica-
tions on the evidence supporting the adverse prognostic rele-
vance of specific patterns of BP variability over a 24-hour period.
8)
Measured home BP values are often reported by patients 
in handwritten log books. Interestingly, it has been shown 
that they are frequently inaccurate and illegible, and do not 
provide immediate insight into the overall time course and 
control of BP.
62) A HBPM device with automated digitized 
data recording capability will help to resolve the problem. 
It should also be considered that HBPM may induce anxi-
ety, resulting in excessive and compulsive BP measurements 
in some patients. Moreover, the finding of transient high or 
low BP readings may lead patients to inappropriate self-mod-
ification of drug dosage or unnecessary clinic visit.
2) Mostly, it 
can be overcome by adequate patient education.
In patients with cardiac arrhythmias, the use of HBPM rais-
es special concerns. In atrial fibrillation or frequent extrasys-
toles, large variation of BP from beat to beat often makes accu-
rate BP measurement impossible. Particularly, BP measure-
ment is virtually difficult with oscillometric devices, the soft-
ware of which is unable to calculate systolic and diastolic BP 
accurately. In such circumstance, the auscultatory method 
still remains a useful option for HBPM in patients with ar-
rhythmias.
2) 
 
Special applications of home blood pressure 
monitoring
When applying HBPM, particular consideration is needed 
in the following clinical situations: in elderly or obese indi-
viduals, pregnant women, those with chronic kidney disease, 
and diabetic patients who have combined hypertension. 
In elderly hypertensive patients, there are several specific fea-
tures, including high WCH prevalence,
63) a more pronounced 
BP variability including excessive morning BP surge,
43) and 
more frequent symptomatic hypotension during treatment 
than in younger patients. Although ABPM appears to be most 
suitable for the diagnosis of these problems, HBPM may 
also be useful in identifying these features and in achieving 
optimal 24-hour BP control in these patients.
In very elderly patients, it may be difficult to use HBPM due 
to physical and intellectual limitations. With the assistance 
of family members, integrated HBPM devices specially de-
signed for the elderly individuals are preferred.
2)
In obese individuals, discrepancies between office and home 
BP are more common, and the severity of obesity appears to 
be associated with a higher prevalence of both WCH and MH.
64) 
An important difficulty in BP measurement for obese indi-
viduals is related to inappropriate cuff size, which may affect 
the measurement accuracy. The use of a regular cuff may lead 
to BP overestimation in obese individuals. For accurate BP 
measurement, it is essential to use an appropriate cuff.
A conical shaped arm, common in obese individuals, makes 
it difficult to fit the cuff to the arm. The use of wrist devices 
may help to avoid these problems and represents a potential 
alternative for HBPM in obese individuals.
1)2)
In pregnant women, early detection and optimal treat-
ment of hypertension can reduce potential risks for both the 
mother and the baby. HBPM can be especially helpful to op-
timize management of hypertension in hypertensive preg-
nant women. In addition, because identification of elevated 
BP is a reliable way to diagnose pre-eclampsia, and regular 
antenatal care and HBPM can improve the chances of detec-
tion.
65) Particularly, HBPM is also very helpful in women with 
previous pre-eclampsia history, who are likely to have a re-
currence.
HBPM devices using the oscillometric technique tend to 
underestimate BP, because of altered hemodynamics often 
observed in pre-eclampsia. Nonetheless, the degree of error 
found in most officially approved devices does not necessar-
ily preclude their use in clinical practice. However, some 
machines have a large unacceptable error, and recommen-
dation remains that each device intended for use in the preg-
nant population should be specially evaluated.
2)
Patients with chronic kidney disease are likely to have co-Soon-Gil Kim   429
existing hypertension and have more frequent states of “non-
dipper” and “reverse dipper”.
66) This is also a common finding 
in patients undergoing hemodialysis or peritoneal dialysis. It 
has been demonstrated that in these patients, adequate BP 
control reduces the rate of renal function deterioration, CV 
morbidity and mortality. The superior prognostic value of 
HBPM, as compared to office BP, has also been demonstrat-
ed, in terms of prediction of composite CV events, end-stage 
renal disease and death.
67)
Because patients with diabetes are very likely to have high 
CV risk, it is crucial to manage BP optimally for diabetic pa-
tients who have combined hypertension. The usefulness of 
HBPM in this population is particularly related to its ability 
to detect MH. Indeed, diabetic patients have a very high prev-
alence of MH detected with HBPM, and are at high risk of de-
veloping stroke and kidney damage.
68) Therefore, out-of of-
fice monitoring of BP should be performed in diabetic patients, 
even in patients with normal office BP particularly in treated 
patients, because of the possibility of detecting high trough BP 
levels.
2) Home BP was proven to be a strong and independent 
predictor of renal function deterioration in diabetic patients, 
and that such deterioration was present even at relatively low 
home BP levels. Based on these observations, it was suggest-
ed that the therapeutic target for these patients should be low-
er than that of office BP.
69) 
Research application of home blood pressure 
monitoring
Using officially validated and fully automated oscillometric 
devices, HBPM becomes a valuable tool to evaluate the BP-low-
ering effect of antihypertensive drugs not only in clinical prac-
tice, but in pharmacologic research. HBPM has several advan-
tages in this indication.
2)
Most importantly, HBPM provides a more accurate and re-
producible estimate of BP compared to office BP, which increas-
es the statistical power of HBPM. HBPM makes it possible to 
minimize the number of patients to be included in clinical tri-
als. As in clinical practice, both placebo and white coat effect is 
frequently observed in conventional office BP measurements 
in the research field. It may also be minimized by the use of 
HBPM.
70)71)
And HBPM can be used as a guide to initiate and titrate an-
tihypertensive therapy in the research setting.
70) It also con-
tributes to assess the duration of the action of antihypertensive 
drugs. This can be achieved by measuring BP before the morn-
ing dose, as a trough BP, and again when the full effect of drug 
is expected, for instance, at midday or in the evening. It is also 
possible to calculate the morning : evening (M/E) ratio, which 
may provide similar information to the trough : peak (T : P) 
ratio, an index often calculated in ABPM and is widely used to 
estimate the duration of action of antihypertensive drugs.
70)
HBPM can be carried out for long periods, in weeks or 
months, providing valuable information on BP changes oc-
curring throughout the trial. Finally, implementing HBPM 
in clinical trials may be motivating for patients, thereby con-
tributes to improved compliance and BP control.
72) 
The reliability of HBPM increased with the use of a proper 
BP measurement schedule. In the research setting, it is also 
advised to use a previously described standardized schedule, 
a 7-day schedule with at least two morning and two evening 
measurements discarding the first day readings, unless there 
are specific reasons to modify it. In clinical trials, only validat-
ed HBPM monitors should be used, with preference for those 
with memory storage for BP readings, or for devices with a 
printout or data download to an external computer, in order 
to prevent reporting bias.
2) 
Conclusion
An accurate estimate of BP can be produced by both ABPM 
and HBPM. And both techniques of BP measurement have 
stronger prognostic values, compared to conventional office 
BP. Although a larger amount of outcome data from clinical 
research has been accumulated for ABPM, HBPM is proven 
to have a potent predictive value for CV outcomes. 
ABPM provides a series of frequent automated BP measure-
ments by programmed intervals throughout a 24 hour period, 
with which BP changes in relatively short periods can be ana-
lyzed. However, repeated performance of ABPM needs special 
consideration because it is relatively expensive and inconve-
nient to apply. On the contrary, HBPM produces repeated me-
asurements of BP in long periods of time. It may be extend-
ed even into a period of one’s life-time. In fact ABPM and HB-
PM are complementary tools in the evaluation and manage-
ment of hypertensive patients. While a preferential role of HB-
PM could lie on the long term management of hypertension, 
ABPM is a useful tool for the initial assessment of hyperten-
sion, and for the evaluation of relatively high risk patients, es-
pecially in those who have target organ damage or diagnosed 
CV diseases.
There is yet to be large clinical outcome data using BP moni-
toring in Korea. Therefore the Korean Ambulatory Blood Pres-
sure (Kor-ABP) Registration study, which is a web-based long-
term registration project (www.korabp.org), had been con-
structed in 2009.
73) At present, about 24 hospitals and insti-
tutions throughout the nation have actively participated in 
this study, and they are increasing in number. Long-term fol-
low-up nation-wide CV outcome data of ABPM is expected.
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